CRYO-CELL INTL INC (CCEL) Fundamental Analysis & Valuation

NYSEARCA:CCEL • US2288951088

Current stock price

3.67 USD
-0.24 (-6.13%)
At close:
3.48 USD
-0.19 (-5.18%)
After Hours:

This CCEL fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

4

1. CCEL Profitability Analysis

1.1 Basic Checks

  • In the past year CCEL has reported negative net income.
  • In the past year CCEL had a positive cash flow from operations.
  • The reported net income has been mixed in the past 5 years: CCEL reported negative net income in multiple years.
  • CCEL had a positive operating cash flow in each of the past 5 years.
CCEL Yearly Net Income VS EBIT VS OCF VS FCFCCEL Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5M -5M

1.2 Ratios

  • CCEL's Return On Assets of -0.75% is in line compared to the rest of the industry. CCEL outperforms 43.00% of its industry peers.
  • With a decent Return On Invested Capital value of 7.64%, CCEL is doing good in the industry, outperforming 73.00% of the companies in the same industry.
  • CCEL had an Average Return On Invested Capital over the past 3 years of 8.32%. This is in line with the industry average of 8.50%.
Industry RankSector Rank
ROA -0.75%
ROE N/A
ROIC 7.64%
ROA(3y)-6.29%
ROA(5y)-2.23%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)8.32%
ROIC(5y)8.46%
CCEL Yearly ROA, ROE, ROICCCEL Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50 -50 -100 -150

1.3 Margins

  • With an excellent Operating Margin value of 13.63%, CCEL belongs to the best of the industry, outperforming 86.00% of the companies in the same industry.
  • In the last couple of years the Operating Margin of CCEL has declined.
  • CCEL's Gross Margin of 77.07% is amongst the best of the industry. CCEL outperforms 92.00% of its industry peers.
  • CCEL's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 13.63%
PM (TTM) N/A
GM 77.07%
OM growth 3Y4.95%
OM growth 5Y-11.79%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y2.57%
GM growth 5Y2.12%
CCEL Yearly Profit, Operating, Gross MarginsCCEL Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 -20 40 60

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

3

2. CCEL Health Analysis

2.1 Basic Checks

  • CCEL has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
  • The number of shares outstanding for CCEL has been reduced compared to 1 year ago.
  • CCEL has more shares outstanding than it did 5 years ago.
  • CCEL has a worse debt/assets ratio than last year.
CCEL Yearly Shares OutstandingCCEL Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2M 4M 6M 8M
CCEL Yearly Total Debt VS Total AssetsCCEL Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M

2.2 Solvency

  • Based on the Altman-Z score of 0.06, we must say that CCEL is in the distress zone and has some risk of bankruptcy.
  • CCEL has a Altman-Z score of 0.06. This is in the lower half of the industry: CCEL underperforms 75.00% of its industry peers.
  • CCEL has a debt to FCF ratio of 1.36. This is a very positive value and a sign of high solvency as it would only need 1.36 years to pay back of all of its debts.
  • The Debt to FCF ratio of CCEL (1.36) is better than 82.00% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 1.36
Altman-Z 0.06
ROIC/WACC0.64
WACC11.93%
CCEL Yearly LT Debt VS Equity VS FCFCCEL Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5M -5M -10M -15M

2.3 Liquidity

  • CCEL has a Current Ratio of 0.63. This is a bad value and indicates that CCEL is not financially healthy enough and could expect problems in meeting its short term obligations.
  • CCEL has a worse Current ratio (0.63) than 87.00% of its industry peers.
  • CCEL has a Quick Ratio of 0.63. This is a bad value and indicates that CCEL is not financially healthy enough and could expect problems in meeting its short term obligations.
  • CCEL has a worse Quick ratio (0.60) than 84.00% of its industry peers.
Industry RankSector Rank
Current Ratio 0.63
Quick Ratio 0.6
CCEL Yearly Current Assets VS Current LiabilitesCCEL Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5M 10M 15M 20M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

1

3. CCEL Growth Analysis

3.1 Past

  • The earnings per share for CCEL have decreased strongly by -1750.00% in the last year.
  • Looking at the last year, CCEL shows a decrease in Revenue. The Revenue has decreased by -1.31% in the last year.
  • CCEL shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 0.27% yearly.
EPS 1Y (TTM)-1750%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-66.67%
Revenue 1Y (TTM)-1.31%
Revenue growth 3Y1.33%
Revenue growth 5Y0.27%
Sales Q2Q%-3.59%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y123.03%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-3.55%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
CCEL Yearly Revenue VS EstimatesCCEL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 10M 20M 30M
CCEL Yearly EPS VS EstimatesCCEL Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 2026 0 -0.5 -1

More info and screens

Find the best growth stocksShow best growing peers

4

4. CCEL Valuation Analysis

4.1 Price/Earnings Ratio

  • CCEL reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • The Price/Forward Earnings ratio is 51.40, which means the current valuation is very expensive for CCEL.
  • CCEL's Price/Forward Earnings is on the same level as the industry average.
  • The average S&P500 Price/Forward Earnings ratio is at 22.24. CCEL is valued rather expensively when compared to this.
Industry RankSector Rank
PE N/A
Fwd PE 51.4
CCEL Price Earnings VS Forward Price EarningsCCEL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40

4.2 Price Multiples

  • 90.00% of the companies in the same industry are more expensive than CCEL, based on the Enterprise Value to EBITDA ratio.
  • 97.00% of the companies in the same industry are more expensive than CCEL, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 4.78
EV/EBITDA 5.98
CCEL Per share dataCCEL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2

4.3 Compensation for Growth

  • CCEL's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

4

5. CCEL Dividend Analysis

5.1 Amount

  • With a Yearly Dividend Yield of 10.23%, CCEL is a good candidate for dividend investing.
  • CCEL's Dividend Yield is rather good when compared to the industry average which is at 0.46. CCEL pays more dividend than 100.00% of the companies in the same industry.
  • Compared to an average S&P500 Dividend Yield of 1.81, CCEL pays a better dividend.
Industry RankSector Rank
Dividend Yield 10.23%

5.2 History

  • CCEL has been paying a dividend for less than 5 years, so it still needs to build a track record.
Dividend Growth(5Y)N/A
Div Incr Years1
Div Non Decr Years1
CCEL Yearly Dividends per shareCCEL Yearly Dividends per shareYearly Dividends per share 2022 2024 2025 0.2 0.4 0.6 0.8

5.3 Sustainability

  • The earnings of CCEL are negative and hence is the payout ratio. CCEL will probably not be able to sustain this dividend level.
DP-1109.12%
EPS Next 2YN/A
EPS Next 3YN/A
CCEL Yearly Income VS Free CF VS DividendCCEL Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5M -5M

More info and screens

Find the best dividend stocksShow peers with best dividend

CCEL Fundamentals: All Metrics, Ratios and Statistics

CRYO-CELL INTL INC

NYSEARCA:CCEL (4/24/2026, 8:25:31 PM)

After market: 3.48 -0.19 (-5.18%)

3.67

-0.24 (-6.13%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)04-14
Earnings (Next)07-13
Inst Owners12.47%
Inst Owner Change-41.71%
Ins Owners41.98%
Ins Owner Change0.79%
Market Cap29.58M
Revenue(TTM)31.57M
Net Income(TTM)-473.50K
Analysts43.33
Price Target8.67 (136.24%)
Short Float %0.26%
Short Ratio0.78
Dividend
Industry RankSector Rank
Dividend Yield 10.23%
Yearly Dividend0.4
Dividend Growth(5Y)N/A
DP-1109.12%
Div Incr Years1
Div Non Decr Years1
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)227.45%
Min EPS beat(2)178.43%
Max EPS beat(2)276.47%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-3.61%
Min Revenue beat(2)-3.88%
Max Revenue beat(2)-3.33%
Revenue beat(4)0
Avg Revenue beat(4)-2.41%
Min Revenue beat(4)-3.88%
Max Revenue beat(4)-0.9%
Revenue beat(8)0
Avg Revenue beat(8)-2.16%
Revenue beat(12)2
Avg Revenue beat(12)-0.97%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)116.67%
EPS NY rev (3m)116.67%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)1.39%
Revenue NY rev (3m)1.39%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 51.4
P/S 0.93
P/FCF 4.78
P/OCF 4.65
P/B N/A
P/tB N/A
EV/EBITDA 5.98
EPS(TTM)-0.33
EYN/A
EPS(NY)0.07
Fwd EY1.95%
FCF(TTM)0.77
FCFY20.9%
OCF(TTM)0.79
OCFY21.48%
SpS3.94
BVpS-1.84
TBVpS-2.19
PEG (NY)N/A
PEG (5Y)N/A
Graham Number0 (-100%)
Profitability
Industry RankSector Rank
ROA -0.75%
ROE N/A
ROCE 9.68%
ROIC 7.64%
ROICexc 8.24%
ROICexgc 8.84%
OM 13.63%
PM (TTM) N/A
GM 77.07%
FCFM 19.48%
ROA(3y)-6.29%
ROA(5y)-2.23%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)8.32%
ROIC(5y)8.46%
ROICexc(3y)8.86%
ROICexc(5y)9.39%
ROICexgc(3y)9.56%
ROICexgc(5y)10.26%
ROCE(3y)10.53%
ROCE(5y)10.71%
ROICexgc growth 3Y10.58%
ROICexgc growth 5Y-24.53%
ROICexc growth 3Y10.79%
ROICexc growth 5Y-22.99%
OM growth 3Y4.95%
OM growth 5Y-11.79%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y2.57%
GM growth 5Y2.12%
F-Score7
Asset Turnover0.5
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 1.36
Debt/EBITDA 1.54
Cap/Depr 17.31%
Cap/Sales 0.54%
Interest Coverage 2.13
Cash Conversion 119.5%
Profit Quality N/A
Current Ratio 0.63
Quick Ratio 0.6
Altman-Z 0.06
F-Score7
WACC11.93%
ROIC/WACC0.64
Cap/Depr(3y)286.14%
Cap/Depr(5y)369.56%
Cap/Sales(3y)10.02%
Cap/Sales(5y)15.31%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-1750%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-66.67%
EPS Next Y123.03%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-1.31%
Revenue growth 3Y1.33%
Revenue growth 5Y0.27%
Sales Q2Q%-3.59%
Revenue Next Year-3.55%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-5.52%
EBIT growth 3Y6.35%
EBIT growth 5Y-11.56%
EBIT Next Year1.6%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y100.23%
FCF growth 3YN/A
FCF growth 5Y-8.91%
OCF growth 1Y-11.72%
OCF growth 3Y-13.86%
OCF growth 5Y-8.34%

CRYO-CELL INTL INC / CCEL Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for CRYO-CELL INTL INC?

ChartMill assigns a fundamental rating of 3 / 10 to CCEL.


What is the valuation status of CRYO-CELL INTL INC (CCEL) stock?

ChartMill assigns a valuation rating of 4 / 10 to CRYO-CELL INTL INC (CCEL). This can be considered as Fairly Valued.


What is the profitability of CCEL stock?

CRYO-CELL INTL INC (CCEL) has a profitability rating of 4 / 10.


Can you provide the financial health for CCEL stock?

The financial health rating of CRYO-CELL INTL INC (CCEL) is 3 / 10.